Patrick Arbuthnot News Today

Earlier this month Cape Town-based vaccine company Afrigen announced a formal collaboration with the US Naid.

Catherine Tomlinson unpacks what this deal may mean for local production of vaccines for Covid-19 and other diseases.

Middle-East Arab News and Opinion - Asharq Al-Awsat is the world’s premier pan-Arab daily newspaper, printed simultaneously each day on four continents in 14 cities

South Africa is grappling with the fourth wave of the coronavirus, driven by the omicron variant. The country is pushing for more vaccinations — and for its own mRNA vaccine.

It is a phobia that can be treated with counselling Enzymes in the stomach make oral vaccines difficult to absorb Needle phobia is when one feels anxious about a needle being inserted into your body, whether to administer medication, vaccines or draw blood. It is an anxiety disorder that can lead some people to faint or send their blood pressure skyrocketing, according to a Health24 article. As South Africa and other countries are inoculating their citizens with Covid-19 vaccines, many people...

The announcement of a R3 billion pledge by SA-born biotech billionaire Dr Patrick Soon-Shiong, 68, to help South Africa in the fight against Covid-19 was a welcome shot in the arm for Covid-weary South Africans this week

The announcement of a R3 billion pledge by SA-born biotech billionaire Dr Patrick Soon-Shiong to help South Africa in the fight against Covid-19 was a welcome shot in the arm for Covid-weary South Africans this week

Wits partners with Biovac to develop skills that will help in producing vaccines By Chulumanco Mahamba Share Johannesburg - Wits University has partnered with Cape Town-based bio-pharmaceutical company Biovac to develop skills to produce viral vectored vaccines in South Africa. Wits University’s Antiviral Gene Therapy Research Unit (AGTRU), via Wits Enterprise, has joined with Cape Town-based bio-pharmaceutical company Biovac in partnership to develop the skills capacity to produce viral vect...

Tuesday 9 March 2021 - 11:00am Director of the antiviral gene therapy research unit at Wits, Professor Patrick Arbuthnot spoke with eNCAs Jane Dutton. Courtesy of #DStv403 JOHANNESBURG - Wits University has teamed up with the pharmaceutical company Biovac to reinforce the countrys vaccine production capabilities. The collaboration will see viral-vectored vaccines being produced in South Africa. These vaccine types use the body cells to develop antibodies to fight t...

8 March 2021 - Wits University The Antiviral Gene Therapy Research Unit via Wits Enterprise has partnered with Biovac to develop the skills capacity to produce viral vectored vaccines in SA. Demonstrating that South Africa has the capability and the skills resources to tackle serious health problems, Wits University’s Antiviral Gene Therapy Research Unit (AGTRU), with Wits Commercial Enterprise acting on its behalf, partnered with Cape Town based bio-pharmaceutical company, Biovac, in a ...